Sustained-Release, Extended-Release, and Other Time-Release Formulations in Neuropsychiatry

被引:29
作者
Andrade, Chittaranjan [1 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Psychopharmacol, Bangalore 560029, Karnataka, India
关键词
EFFICACY; ZOLPIDEM; PHARMACOKINETICS; METHYLPHENIDATE; TOLERABILITY; PAROXETINE; INSOMNIA; SAFETY; MG;
D O I
10.4088/JCP.15f10219
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Pills and capsules may release their contents within minutes of ingestion; these are immediate-release formulations. Pills and capsules may also release their contents after a time lag, or a little at a time, or in some other predetermined way; these are time-release formulations. Many drugs in psychiatry have been time-release formulated to reduce their local adverse effects in the gastrointestinal tract, to reduce adverse effects associated with peak blood levels, or to artificially extend their half-life. Time-release formulations are associated with the added advantages of convenience of dosing, improved compliance, and less fluctuation in blood levels across the course of the day. A disadvantage of time-release formulations is that they may be incompletely absorbed; this is a serious issue in patients with acute or chronic intestinal hurry disorders, such as gastroenteritis or irritable bowel syndrome. Time-release formulations may also be more expensive than immediate-release formulations. (C) Copyright 2015 Physicians Postgraduate Press, Inc.
引用
收藏
页码:E995 / E999
页数:5
相关论文
共 25 条
[1]  
Andrade C, 2000, Indian J Psychiatry, V42, P302
[2]   OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder [J].
Antoni Ramos-Quiroga, J. ;
Corominas, Margarida ;
Castells, Xavier ;
Bosch, Rosa ;
Casas, Miguel .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) :1121-1131
[3]  
Barkin Robert L, 2007, Am J Ther, V14, P299, DOI 10.1097/MJT.0b013e31804c7292
[4]  
Bosse George M., 1992, Journal of Emergency Medicine, V10, P719, DOI 10.1016/0736-4679(92)90531-W
[5]   Are immediate- and extended-release drugs interchangeable? [J].
Cohen, Dan ;
Loonen, Anton J. M. .
ACTA PSYCHIATRICA SCANDINAVICA, 2013, 127 (01) :78-80
[6]   The safety and tolerability of zolpidem -: an update [J].
Darcourt, G ;
Pringuey, D ;
Sallière, D ;
Lavoisy, J .
JOURNAL OF PSYCHOPHARMACOLOGY, 1999, 13 (01) :81-93
[7]  
Eaddy Michael, 2003, Manag Care Interface, V16, P22
[8]  
FAWCETT JA, 1982, PHARMACOTHERAPY, V2, P243
[9]   Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression [J].
Golden, RN ;
Nemeroff, CB ;
McSorley, P ;
Pitts, CD ;
Dubé, EM .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (07) :577-584
[10]  
Golden Robert N, 2003, Psychopharmacol Bull, V37 Suppl 1, P176